Wall Street Thinks SpaceX Is a Buy. Here's Why I'm Not So Sure

SpaceX’s Q2 revenue rose 92% YoY to $7.8B and its net loss narrowed to $541M (vs. $1.0B prior year), but the stock still sits below its $150 IPO opening price. The article attributes the downside to upcoming share unlock/lockup expirations (potential increased selling) and a valuation premium (P/S ~65.7), leaving little margin for error. While Wall Street targets ~50% upside over the next year (price targets up to $450; Yahoo average ~$222.32, implying ~58% upside), the piece argues execution risk could drive significant downside if milestones like Starship flight cadence or AI/deal wins disappoint.

Analysis

The stock is being priced as if every strategic option converts cleanly into durable cash flow, which is the wrong mental model for a high-multiple, still-loss-making platform. At this valuation, revenue growth is a weak signal; what matters is whether incremental volume turns into margin, free cash flow, and repeatable cadence without forcing dilution or discounting. That makes the next 1-3 months more about supply overhang and investor positioning than fundamentals.

The second-order read-through is more interesting than the company itself: if launch costs truly step down, legacy launch economics get squeezed and adjacent space/telecom players may need to spend faster just to defend share. But that same dynamic can also hurt the bull case for the stock, because cheaper launches expand the addressable market faster than they improve near-term monetization, which means gross bookings can rise while equity value still compresses if cash conversion lags. In other words, the market can get more competition and more TAM at the same time.

The consensus is underestimating how much good news is already in the tape and overestimating how little execution slippage will matter. The upside case requires a rare combination: light insider selling, multiple clean flight readouts, and evidence that newer businesses produce recurring, high-quality revenue rather than headline partnerships. Falsifiers are straightforward: heavy post-lockup supply, any meaningful launch setback, or another quarter where growth outpaces margin and cash generation.

Key Decisions for Investors

• Avoid initiating a fresh long SPCX here; the risk/reward is poor unless you have a 12-18 month horizon and a willingness to underwrite execution with near-zero margin for error.
• If you must express a bearish view, use a 3-6 month SPCX put spread into the next supply/lockup window rather than outright shorting; it defines risk if the stock squeezes on announcement-driven headlines.
• If already long SPCX, trim into strength and keep only a residual position until insider-sale data and launch cadence confirm the thesis; use a 10-15% drawdown from current levels as the tactical pain threshold.
• Set a catalyst alert on two consecutive successful Starship flights plus insider filing pace; if both improve and selling remains muted, cover tactical shorts and reassess the multiple.
• Do not chase any single customer announcement as a valuation reset unless it comes with disclosed recurring revenue or margin impact; headline partnerships alone are unlikely to justify the current multiple.